Search Articles — Sudonull

Search Results

In this project

Graphics Modes of Soviet PCs of the 1980s

https://sudonull.com/graphics-modes-of-soviet-pcs-of-the-1980s

Study 70+ video and audio modes of USSR home computers: from monochrome to 256 colors, CGA/EGA clones. Tables, Russian National Standards for developers.

D-Wave solved the wiring problem in quantum PCs

https://sudonull.com/d-wave-solved-the-wiring-problem-in-quantum-pcs

D-Wave's breakthrough in cryogenic on-chip qubit control eliminates the scaling problem. Learn how this will change the quantum computing market.

DietPi 10.2: Immich, uv and updates for ARM

https://sudonull.com/dietpi-10-2-immich-uv-and-updates-for-arm

DietPi 10.2 for single-board PCs: new Immich ML, uv, RustDesk. Minimal images 130 MB, Debian 12. Learn about migration and improvements for developers.

Nvidia and Microsoft ARM Computers: RTX Spark on Windows

https://sudonull.com/nvidia-and-microsoft-arm-computers-rtx-spark-on-windows

Nvidia and Microsoft are preparing ARM PCs with the RTX Spark chip and AI performance of 1 petaflop. Learn about the implications for Intel, AMD, and the market. Read the details.

Ripple in ATX PSU: cause of PC glitches

https://sudonull.com/ripple-in-atx-psu-cause-of-pc-glitches

Learn why ATX power supplies cause intermittent failures in PCs through +12V ripple. Diagnosis with oscilloscope, capacitor replacement. Instructions for middle/senior dev.

From other projects

ARM shares surged 15%: partnership with OpenAI and AI processor

https://ymaho.com/arm-shares-surged-15-partnership-with-openai-and-ai-processor

Analysis of reasons for ARM shares rising 15%: partnership with OpenAI, announcement of RTX Spark from NVIDIA, and transition to ARM in PCs. Who won and who lost. Read details.

CRISPR in vivo reduces cholesterol by 60% in VERVE-102 study

https://ymaho.com/crispr-in-vivo-reduces-cholesterol-by-60-in-verve-102-study

Single infusion of VERVE-201 sustainably lowers LDL by more than 60%. Learn how CRISPR editing is changing the hypercholesterolemia therapy market. Read the analysis.

Cholesterol gene therapy VERVE-102: NEJM data, LDL reduction by 62%

https://ymaho.com/cholesterol-gene-therapy-verve-102-nejm-data-ldl-reduction-by-62

NEJM published phase 1b results of gene therapy VERVE-102: LDL reduction by 62% after a single injection. Analysis of efficacy, risks, and prospects for patients with hypercholesterolemia. Read more.

Trending Now